These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 28579485

  • 1. Cerebral metabolic change in Parkinson's disease patients with anxiety: A FDG-PET study.
    Wang X, Zhang J, Yuan Y, Li T, Zhang L, Ding J, Jiang S, Li J, Zhu L, Zhang K.
    Neurosci Lett; 2017 Jul 13; 653():202-207. PubMed ID: 28579485
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.
    Berding G, Odin P, Brooks DJ, Nikkhah G, Matthies C, Peschel T, Shing M, Kolbe H, van Den Hoff J, Fricke H, Dengler R, Samii M, Knapp WH.
    Mov Disord; 2001 Nov 13; 16(6):1014-22. PubMed ID: 11748732
    [Abstract] [Full Text] [Related]

  • 4. The prominent role of serotonergic degeneration in apathy, anxiety and depression in de novo Parkinson's disease.
    Maillet A, Krack P, Lhommée E, Météreau E, Klinger H, Favre E, Le Bars D, Schmitt E, Bichon A, Pelissier P, Fraix V, Castrioto A, Sgambato-Faure V, Broussolle E, Tremblay L, Thobois S.
    Brain; 2016 Sep 13; 139(Pt 9):2486-502. PubMed ID: 27538418
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neuroimaging markers of motor and nonmotor features of Parkinson's disease: an 18f fluorodeoxyglucose positron emission computed tomography study.
    Huang C, Ravdin LD, Nirenberg MJ, Piboolnurak P, Severt L, Maniscalco JS, Solnes L, Dorfman BJ, Henchcliffe C.
    Dement Geriatr Cogn Disord; 2013 Sep 13; 35(3-4):183-96. PubMed ID: 23445555
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Cerebral glucose metabolism in Parkinson's disease with dementia].
    Ma AJ, Zhang BS, Pan XD, Gao S, Li ZG.
    Zhonghua Yi Xue Za Zhi; 2008 Oct 14; 88(37):2623-8. PubMed ID: 19080710
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Age- and sex-associated changes in cerebral glucose metabolism in normal healthy subjects: statistical parametric mapping analysis of F-18 fluorodeoxyglucose brain positron emission tomography.
    Kim IJ, Kim SJ, Kim YK.
    Acta Radiol; 2009 Dec 14; 50(10):1169-74. PubMed ID: 19922315
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Abnormal metabolic brain network associated with Parkinson's disease: replication on a new European sample.
    Tomše P, Jensterle L, Grmek M, Zaletel K, Pirtošek Z, Dhawan V, Peng S, Eidelberg D, Ma Y, Trošt M.
    Neuroradiology; 2017 May 14; 59(5):507-515. PubMed ID: 28386687
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease.
    Klein RC, de Jong BM, de Vries JJ, Leenders KL.
    Mov Disord; 2005 Aug 14; 20(8):1021-30. PubMed ID: 15858809
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.